A six-month reprieve, the last card theaters have drawn to survive
In May 2026, the Ministry of Culture, Sports and Tourism and the **Korean Film Council** formed a public-private consultation body. The goal is one: a voluntary agreement on '**holdback**', which delays the release of movies on OTT platforms for a certain period after their theatrical release. This negotiation, which aims to be finalized in August, seems like the industry's last line of defense to protect the collapsing theater ecosystem.
The gap between theaters and streaming has vanished. Once, a film would spend months in cinemas before moving to another platform. Now that interval has shrunk to just a few weeks, and sometimes releases are simultaneous. There’s no longer any compelling reason for audiences to rush to the theater.
The government and industry have revisited the “holdback” because of this. This agreement to postpone a film’s release on OTT for a certain period after its theatrical debut is an attempt to preserve, through policy, the very reason theaters exist. Negotiations are underway, aiming for a finalization in August.
The direct cause of the holdback debate is the collapse of the theatrical release window. Audiences weigh the film they can see in theaters against the one they can watch at home a few weeks later, increasingly opting for the latter. As the exclusive theatrical window disappears, so does the reason to go to the theater.
For theater operators, this is a matter of survival. When audiences dwindle, the number of screens shrinks, and when screens shrink, the opportunities for film releases diminish. Holdback is a mechanism designed to break this vicious cycle by restoring a minimum amount of exclusive time to theaters in a systematic way.
The essence of a holdback is to give theaters more time. Whether it’s six months or a few months, during that grace period the theater regains its exclusive distribution position. The key point, however, is that this is not a regulation but an “autonomous agreement.” This is because the interests of content creators and platforms collide head‑on.
Producers want to rush into OTT sales to recoup their investments, while platforms want to secure new releases as quickly as possible. On the other hand, theaters want to delay that time. The difficulty in **holdback** negotiations lies not in the technology, but in the equation of these interests.
Coldly speaking, holdback is not a cause but a prescription that treats symptoms. The reason audiences leave the theater is not solely due to the ticket line. It is the result of a combination of higher ticket prices, the overwhelming convenience of watching at home, and the disappearance of worthwhile mid‑range films.
Increasing the gap between showtimes does not solve all these problems. When the reason to go to the theater has weakened, simply buying time is not enough to bring back the audience. A **holdback** is a hemostatic that slows down bleeding, not a treatment that cures the disease.
The government is increasing support for the film industry by 80% and establishing an investment fund worth over 10 billion won, going as far as to hold back. This is an all-out effort to protect the collapsing ecosystem. However, the success or failure of all these measures ultimately depends on one question: why should audiences go to the theater.
While the holdback buys us time, the industry must deliver answers within that window. If we fail to restore the unique experience that only a theater can offer, or the reasons to see a film in a theater, the six‑month moratorium will slip away again. The final card isn’t about time itself, but about what fills that time.